Ditchcarbon
  • Contact
  1. Organizations
  2. Lantheus Holdings, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

Lantheus Holdings, Inc. Sustainability Profile

Company website

Lantheus Holdings, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 1956, the company has established itself as a leader in the development and commercialisation of innovative diagnostic and therapeutic products, particularly in the fields of oncology and cardiovascular imaging. Lantheus is renowned for its advanced imaging agents, including the widely used PET imaging agent, which aids in the detection and management of various cancers. The company’s commitment to enhancing patient care through precision medicine has positioned it favourably within the market. With a strong focus on research and development, Lantheus continues to achieve significant milestones, solidifying its reputation as a trusted partner in the healthcare community.

DitchCarbon Score

How does Lantheus Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Lantheus Holdings, Inc.'s score of 25 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

38%

Let us know if this data was useful to you

Lantheus Holdings, Inc.'s reported carbon emissions

Lantheus Holdings, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company has not disclosed any commitments to the Science Based Targets initiative (SBTi) or other climate pledges. As such, there are no specific figures regarding their Scope 1, 2, or 3 emissions, nor any inherited data from a parent organisation. In the absence of concrete emissions data or reduction commitments, Lantheus Holdings, Inc. appears to be in the early stages of developing a comprehensive climate strategy. The lack of reported emissions and targets highlights a potential area for growth in their sustainability efforts, particularly as the industry increasingly prioritises climate action and transparency.

How Carbon Intensive is Lantheus Holdings, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Lantheus Holdings, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Lantheus Holdings, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Lantheus Holdings, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Lantheus Holdings, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Lantheus Holdings, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Lantheus Holdings, Inc.'s Emissions with Industry Peers

GE Healthcare Inc.

US
•
Health and social work services (85)
Updated 3 months ago

Medtronic

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 17 days ago

Mallinckrodt plc

IE
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Agfa Gevaert

BE
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 13 days ago

Cardinal Health

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Hologic

US
•
Research and development services (73)
Updated 26 days ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251211.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy